Society for Basic Urologic Research 2021 Annual Meeting: Molecular Mechanisms of Urological Diseases and Treatment Resistance

泌尿基础研究学会2021年年会：泌尿系统疾病的分子机制及治疗耐药性

• 批准号: 10384214
• 负责人: Jindan Yu
• 金额: $ 0.5万
• 依托单位: NORTHWESTERN UNIVERSITY AT CHICAGO
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-11-03 至 2022-10-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10384214
• 关键词: Address; Area; Award; Basic Science; Benign; Bioinformatics; Biological Markers; Biology; CRISPR/Cas technology; Cell Lineage; Clinic; Clinical; Clinical Research; Clustered Regularly Interspaced Short Palindromic Repeats; Collaborations; Development; Disabled Persons; Disadvantaged; Disease; Disease Resistance; Emerging Technologies; Endocrine; Environment; Environmental Risk Factor; Epigenetic Process; Fostering; Funding; Genetic; Goals; Immune response; Immunotherapy; Individual; Infection; Inflammation; Intention; Interdisciplinary Communication; Knowledge; Learning; Malignant - descriptor; Medical; Medical Students; Methodology; Minority; Modeling; Molecular; National Institute of Diabetes and Digestive and Kidney Diseases; Oral; Organoids; Pathway interactions; Persons; Physicians; Postdoctoral Fellow; Prevention; Process; Regulation; Request for Applications; Request for Proposals; Research; Research Personnel; Science; Scientist; Societies; Technology; Thinking; Transgenic Organisms; Translating; Translational Research; Travel; Urologic Diseases; Urology; Woman; career; cost; diagnostic strategy; doctoral student; environmental health disparity; epigenetic regulation; ethnic minority population; health disparity; interest; meetings; novel; novel diagnostics; novel therapeutics; patient derived xenograft model; posters; pre-clinical; racial and ethnic; recruit; stem cells; symposium; targeted treatment; therapy resistant; tool; urologic

This application requests support for the Society for Basic Urologic Research (SBUR) 2021 Annual Meeting entitled, “Molecular Mechanisms of Urological Diseases and Treatment Resistance”, which will be held on November 4-7, 2021 at the JW Marriott Orlando Grande Lakes, Orlando, FL. This conference has been held annually since 1992 and provides a unique environment to learn about the most recent advances in basic, translational, and preclinical urologic research, in addition to providing a dynamic forum for discussing how these advances could be implemented for the prevention and treatment of urological diseases. Much has been learned over the last decade regarding the molecular determinants and key pathways that regulate normal and disease processes, and a wide variety of novel therapeutic and diagnostic strategies have emerged as a result. Thus, this year’s meeting will focus on a few areas that are emerging as the cutting-edge advances in urology, including: 1) Emerging Technologies and Models for Urological Research; 2) Endocrine and Genetic regulations in Urological Biology; 3) Epigenetic Regulations of Urological Development and Diseases; 4) Infection, Inflammation, and Immune Response in Urological Biology; 5) Biomarkers, Environmental Factors, and Health Disparities in Urological Diseases; 6) Urological Stem cells, Lineage Plasticity, and Treatment Resistance. The support from this application will be used to provide 24 Travel Awards and 4 Minority Scholar Awards to disadvantaged, poorly represented, trainees and junior to mid-career investigators to defray travel costs, with the intention of providing much-needed encouragement and promotion to a career in urologic research and of enhancing the diversity of conference attendees. In addition to highlighting recent advances and identifying key knowledge gaps, the primary goals of the conference are: 1) Discuss recent advances in studying the molecular mechanisms of urologic development and diseases using contemporary technologies, with emphasis on novel methodologies and tools, genetics, epigenetics, infection, inflammation and immune response, environmental factors and health disparity, and stem cells and lineage plasticity; 2) Identify critical knowledge gaps and stimulate approaches to address them; 3) Attract leading scientists from diverse fields in malignant and benign urology; 4) Promote interactions between basic, translational and clinical research scientists of diverse backgrounds and facilitate cross-disciplinary communication and collaboration; 5) Foster the active participation of women, minorities, the disabled, and early career investigators by providing them opportunities to present and discuss cutting-edge science and enhancing their integration into the field; and 6) Disseminate and facilitate novel discoveries in urologic diseases. An attendance of at least 250 is expected, and we will recruit a large variety of clinician, physician-scientist, and basic researcher attendees, with special emphasis on early-career investigators and groups typically underrepresented in urologic research. Finally, a robust plan is in place for publicizing the conference and the support, if awarded, by NCI and NIDDK.

本申请请求支持基础泌尿外科研究学会（SBUR）2021年年会 题为“泌尿系统疾病的分子机制和治疗耐药性”，将于 2021年11月4日至7日在佛罗里达州奥兰多格兰德湖JW万豪酒店举行。 自1992年以来，每年举办一次，提供了一个独特的环境，了解基础， 翻译和临床前泌尿学研究，除了提供一个动态的论坛，讨论如何 这些进展可用于预防和治疗泌尿系统疾病。了很多 在过去的十年里，我们了解到了调节正常和 疾病过程，以及各种各样的新的治疗和诊断策略已经出现。 因此，今年的会议将集中在一些领域，这些领域正在成为泌尿外科的前沿进展， 包括：1）泌尿外科研究的新兴技术和模型; 2）内分泌和遗传 泌尿系统生物学法规; 3）泌尿系统发育和疾病的表观遗传学法规; 4） 泌尿生物学中的感染、炎症和免疫反应; 5）生物标志物，环境因素， 泌尿系统疾病的健康差异; 6）泌尿系统干细胞，谱系可塑性和治疗 阻力从这个应用程序的支持将用于提供24个旅游奖和4个少数民族学者 向处境不利、任职人数不足的受训人员和初级至中级调查员发放奖金，以支付旅费 费用，目的是提供急需的鼓励和促进泌尿科的职业生涯 研究和提高与会者的多样性。除了强调最近的进展之外， 并确定关键的知识差距，会议的主要目标是：1）讨论最近的进展， 利用现代技术研究泌尿系统发育和疾病的分子机制， 重点是新的方法和工具，遗传学，表观遗传学，感染，炎症和免疫 反应，环境因素和健康差异，干细胞和谱系可塑性; 2）确定关键 知识差距，并激励解决这些问题的方法; 3）吸引来自不同领域的顶尖科学家， 恶性和良性泌尿外科; 4）促进基础，转化和临床研究之间的互动 不同背景的科学家，促进跨学科的沟通和合作; 5）促进 妇女、少数民族、残疾人和早期职业调查人员的积极参与， 提供机会介绍和讨论前沿科学并促进其融入该领域;以及6） 传播和促进泌尿系统疾病的新发现。预计至少有250人出席， 我们将招募各种各样的临床医生，医生-科学家和基础研究人员参加，特别是 强调早期职业研究者和在泌尿外科研究中代表性不足的群体。最后 制定了强有力的计划，以宣传会议以及NCI和NIDDK提供的支持（如果提供）。